The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods

The anticancer study of nitrogen-chelating ligands can be of tremendous help in choosing ligands for the anticancer metal complexes design especially with ruthenium(II). The inhibitory anticancer activities of some nitrogen-chelating ligands containing bis-pyrazole, bipyridine, and phenanthroline we...

Full description

Saved in:
Bibliographic Details
Main Authors: Adebayo A. Adeniyi, Peter A. Ajibade
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Bioinorganic Chemistry and Applications
Online Access:http://dx.doi.org/10.1155/2018/5796287
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850174998831955968
author Adebayo A. Adeniyi
Peter A. Ajibade
author_facet Adebayo A. Adeniyi
Peter A. Ajibade
author_sort Adebayo A. Adeniyi
collection DOAJ
description The anticancer study of nitrogen-chelating ligands can be of tremendous help in choosing ligands for the anticancer metal complexes design especially with ruthenium(II). The inhibitory anticancer activities of some nitrogen-chelating ligands containing bis-pyrazole, bipyridine, and phenanthroline were studied using experimental screening against cancer cell and theoretical docking methods. In vitro anticancer activities showed compound 11 as the most promising inhibitor, and the computational docking further indicates its strong inhibitory activities towards some cancer-related receptors. Among the twenty-one modelled ligands, pyrazole-based compounds 7, 11, and 15 are the most promising inhibitors against the selected receptors followed by 18 and 21 which are derivatives of pyridine and phenanthroline, respectively. The presence of the carboxylic unit in the top five ligands that displayed stronger inhibitory activities against the selected receptors is an indication that the formation of noncovalent interactions such as hydrogen bonding and a strong electron-withdrawing group in these compounds are very important for their receptor interactions. The thermodynamic properties, the polarizabilities, and the LUMO energy of the compounds are in the same patterns as the observed inhibitory activities.
format Article
id doaj-art-d71e95ade73a41ab905bc922106c631c
institution OA Journals
issn 1565-3633
1687-479X
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Bioinorganic Chemistry and Applications
spelling doaj-art-d71e95ade73a41ab905bc922106c631c2025-08-20T02:19:33ZengWileyBioinorganic Chemistry and Applications1565-36331687-479X2018-01-01201810.1155/2018/57962875796287The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking MethodsAdebayo A. Adeniyi0Peter A. Ajibade1School of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X01, Scottsville, Pietermaritzburg 3201, South AfricaSchool of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X01, Scottsville, Pietermaritzburg 3201, South AfricaThe anticancer study of nitrogen-chelating ligands can be of tremendous help in choosing ligands for the anticancer metal complexes design especially with ruthenium(II). The inhibitory anticancer activities of some nitrogen-chelating ligands containing bis-pyrazole, bipyridine, and phenanthroline were studied using experimental screening against cancer cell and theoretical docking methods. In vitro anticancer activities showed compound 11 as the most promising inhibitor, and the computational docking further indicates its strong inhibitory activities towards some cancer-related receptors. Among the twenty-one modelled ligands, pyrazole-based compounds 7, 11, and 15 are the most promising inhibitors against the selected receptors followed by 18 and 21 which are derivatives of pyridine and phenanthroline, respectively. The presence of the carboxylic unit in the top five ligands that displayed stronger inhibitory activities against the selected receptors is an indication that the formation of noncovalent interactions such as hydrogen bonding and a strong electron-withdrawing group in these compounds are very important for their receptor interactions. The thermodynamic properties, the polarizabilities, and the LUMO energy of the compounds are in the same patterns as the observed inhibitory activities.http://dx.doi.org/10.1155/2018/5796287
spellingShingle Adebayo A. Adeniyi
Peter A. Ajibade
The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods
Bioinorganic Chemistry and Applications
title The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods
title_full The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods
title_fullStr The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods
title_full_unstemmed The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods
title_short The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods
title_sort anticancer activities of some nitrogen donor ligands containing bis pyrazole bipyridine and phenanthroline moiety using docking methods
url http://dx.doi.org/10.1155/2018/5796287
work_keys_str_mv AT adebayoaadeniyi theanticanceractivitiesofsomenitrogendonorligandscontainingbispyrazolebipyridineandphenanthrolinemoietyusingdockingmethods
AT peteraajibade theanticanceractivitiesofsomenitrogendonorligandscontainingbispyrazolebipyridineandphenanthrolinemoietyusingdockingmethods
AT adebayoaadeniyi anticanceractivitiesofsomenitrogendonorligandscontainingbispyrazolebipyridineandphenanthrolinemoietyusingdockingmethods
AT peteraajibade anticanceractivitiesofsomenitrogendonorligandscontainingbispyrazolebipyridineandphenanthrolinemoietyusingdockingmethods